ebook Munafa Stock Market Course + Intraday & FNO calls  

       

NOVARTIND announcements Novartis India announcements and dividends declared NSE

Novartis India Complete list of announcements declared & dividend announcements by Novartis India NOVARTIND

Novartis India NOVARTIND listed on NSE and deals in Pharmaceuticals

Announcements and dividends declared by Novartis India NOVARTIND

Novartis India MD Amitabh Dube appointed as OPPI president
Amitabh Dube has been appointed as the new president of OPPI for a two-year term. Dube currently serves as the Country President and Managing Director of Novartis India. He brings nearly three decades of extensive pharmaceutical industry experience to his
Announcement as on 10 September 2026

Novartis India buys Minipress brands from Pfizer for ?1,250 crore
The company's board approved the transaction on Monday, following which Novartis India executed an asset purchase agreement and trademark assignment deeds with Pfizer Inc and Pfizer Products Inc
Announcement as on 07 September 2026

Novartis India to acquire Pfizer's 'Minipress' trademark for ?1,250 crore
Novartis India Ltd on Monday announced that its Board of Directors has approved the acquisition of the trademarks 'Minipress' and 'Minipres' from Pfizer Inc. USA and Pfizer Products Inc. USA for a total consideration of approximately Rs 1,250 crore. In a r
Announcement as on 07 September 2026

360 One Group CEO Bhagat buys 1.3 lakh shares of Novartis India for Rs 22 cr
Karan Bhagat acquired 1.3 lakh Novartis India shares for nearly Rs 22 crore. His firm Kyrush Investments sold an equal number of shares in the transaction. Novartis India also announced acquiring trademarks from Pfizer for Rs 1,250 crore. Earlier, Novartis
Announcement as on 07 September 2026

Novartis India to acquire Pfizer's 'Minipress' trademark for Rs 1,250 crore
Novartis India will acquire the Minipress and Minipres trademarks and related intellectual property from Pfizer for about ?1,250 crore. Minipress XL, used for hypertension and benign prostatic hyperplasia, generated ?228.6 crore in revenue as of July 2026,
Announcement as on 07 September 2026

Announcements by Novartis India first page | Next page |

NOVARTIND Novartis India current price & indicator signals

Moving Averages for Novartis India

  • 5Day Average: 1753.34
  • 12Day Average: 1791.74
  • 20Day Average: 1876.62
  • 50Day Average: 1856.76
  • 100Day Average: 1691.75
  • 150Day Average: 1485.32
  • 200Day Average: 1296.65

NOVARTIND Indicators & signals

Indicator MACD (12,26,9)

1797.41, 1845.94, -25.81
Indicator MACD is in negative zone

Indicator ADX (14)

30.29, 13.38, 25.01
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 57
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of NOVARTIND Novartis India are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
03 Tue Nov 2026 1722.40 1672.50 to 1744.10 0.27% 0.71 times
02 Mon Nov 2026 1717.70 1693.30 to 1799.60 1.49% 1.1 times
30 Fri Oct 2026 1692.40 1660.00 to 1802.00 -6.64% 0.99 times
29 Thu Oct 2026 1812.80 1779.80 to 1834.00 -0.47% 0.23 times
28 Wed Oct 2026 1821.40 1802.60 to 1855.40 -1.43% 0.22 times
27 Tue Oct 2026 1847.80 1792.80 to 1858.10 3.22% 0.4 times
26 Mon Oct 2026 1790.20 1775.60 to 1861.90 -1.88% 0.65 times
23 Fri Oct 2026 1824.50 1642.20 to 1884.50 8.31% 3.81 times
22 Thu Oct 2026 1684.50 1665.00 to 1813.80 -4.72% 1.44 times
21 Wed Oct 2026 1768.00 1755.50 to 1896.30 -7.99% 0.84 times
19 Mon Oct 2026 1921.60 1869.70 to 1940.00 1.26% 0.31 times
16 Fri Oct 2026 1897.60 1850.00 to 1949.10 -2.19% 0.82 times

Videos related to: NOVARTIND announcements Novartis India announcements and dividends declared NSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

NOVARTIND announcements Novartis India announcements and dividends declared NSE

 

Back to top